Skip to main content

Table 2 Laboratory values

From: Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

Tests Reference Median Range HR p value
HCT (%) 41–53 37.80 30.70 – 44.6 1.03 0.73
Hgb (g/dL) 13.5–17.5 13.20 10.40 – 15.5 1.14 0.59
Bilt (mg/dL) 0–1 0.65 0.20 – 14.6 1.31 0.02*
SGOT (mg/dL) 10–40 37.50 17 – 97 0.99 0.79
SGPT (mg/dL) 10–55 28.50 12 – 121 0.98 0.21
AP (U/L) 45–115 111.50 58 – 434 1 0.93
GLU (mg/dL) 70–110 114 69 – 247 0.99 0.88
BUN (mg/dL) 8–25 13.50 8 – 25 0.96 0.51
Cr (mg/dL) 0.60–1.50 0.80 0.50 – 1.90 0.49 0.42
LDH (U/L) 110–210 196.50 69 – 1116 0.99 0.07
CA19-9 (U/mL) 37 360 11 – 38000 1 0.28
log CA19-9 (U/mL) - 2.55 1.04 – 4.57 1.32 0.04*
log CA19-9 dif (U/mL) - 5.81 1.38 – 10.50 1.15 0.34
  1. HCT = hematocrit; Hgb = hemoglobin; Bilt = total bilirubin; SGOT = aspartate transaminase; SGPT = alanine transaminase; AP = Alkaline Phosphatase; GLU = glucose; BUN = Blood Urea Nitrogen; Cr = creatinine; LDH = Lactic dehydrogenase; CA19-9 = tumor marker; log CA19-9 = logarithm of CA19-9; log CA19-9 dif = difference between the logarithm of pre- and post-therapy CA19-9 levels. HR = Hazard ratio for Overall Survival after univariate analysis. P value = level of significance.